SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5f9o'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GTI_F_CCSF47_0
(GLUTATHIONE
S-TRANSFERASE)
5f9o CLADE A/E 93TH057
HIV-1 GP120 CORE
CH235.9 HEAVY CHAIN

(Human
immunodeficiency
virus
1;
Homo
sapiens)
4 / 5 THR G 430
LEU G 122
GLY G 124
LYS H  74
None
1.23A 1gtiF-5f9oG:
undetectable
1gtiF-5f9oG:
20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JQD_A_HSMA600_1
(HISTAMINE
N-METHYLTRANSFERASE)
5f9o CLADE A/E 93TH057
HIV-1 GP120 CORE

(Human
immunodeficiency
virus
1)
4 / 7 PHE G 210
VAL G 108
TRP G 112
TRP G 427
None
1.48A 1jqdA-5f9oG:
undetectable
1jqdA-5f9oG:
20.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HC4_A_VDXA525_2
(VITAMIN D RECEPTOR)
5f9o CLADE A/E 93TH057
HIV-1 GP120 CORE

(Human
immunodeficiency
virus
1)
4 / 7 LEU G 259
LEU G 453
ILE G 272
SER G 274
None
1.21A 2hc4A-5f9oG:
undetectable
2hc4A-5f9oG:
20.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IGT_C_SAMC1003_1
(SAM DEPENDENT
METHYLTRANSFERASE)
5f9o CLADE A/E 93TH057
HIV-1 GP120 CORE
CH235.9 HEAVY CHAIN

(Human
immunodeficiency
virus
1;
Homo
sapiens)
4 / 4 ASP H  52
ASP G 368
ASP H  31
GLY G 473
None
1.47A 2igtC-5f9oH:
undetectable
2igtC-5f9oH:
19.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YA7_B_ZMRB1776_2
(NEURAMINIDASE A)
5f9o CH235.9 HEAVY CHAIN
(Homo
sapiens)
4 / 6 ASP H  52
ILE H  51
LEU H  79
TYR H  27
None
1.07A 2ya7B-5f9oH:
undetectable
2ya7B-5f9oH:
20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YA7_C_ZMRC1776_2
(NEURAMINIDASE A)
5f9o CLADE A/E 93TH057
HIV-1 GP120 CORE

(Human
immunodeficiency
virus
1)
4 / 6 ASP G 440
ILE G 326
GLN G 422
GLU G 381
None
None
EPE  G 514 ( 4.6A)
None
1.40A 2ya7C-5f9oG:
undetectable
2ya7C-5f9oG:
19.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YA7_D_ZMRD1776_2
(NEURAMINIDASE A)
5f9o CH235.9 HEAVY CHAIN
(Homo
sapiens)
4 / 6 ASP H  52
ILE H  51
LEU H  79
TYR H  27
None
1.07A 2ya7D-5f9oH:
undetectable
2ya7D-5f9oH:
20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G1U_B_ADNB438_2
(ADENOSYLHOMOCYSTEINA
SE)
5f9o CH235.9 HEAVY CHAIN
(Homo
sapiens)
3 / 3 THR H 119
GLU H 157
HIS H 209
None
0.83A 3g1uB-5f9oH:
undetectable
3g1uB-5f9oH:
19.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HUO_A_PNNA302_0
(CTX-M-9
EXTENDED-SPECTRUM
BETA-LACTAMASE)
5f9o CH235.9 HEAVY CHAIN
(Homo
sapiens)
4 / 6 LEU H 198
GLY H 199
ALA H 134
PRO H 135
None
0.53A 3huoA-5f9oH:
undetectable
3huoA-5f9oH:
20.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D1Y_A_RBFA1176_1
(PUTATIVE PROTEASE I)
5f9o CLADE A/E 93TH057
HIV-1 GP120 CORE

(Human
immunodeficiency
virus
1)
4 / 8 ASN G 392
TRP G 338
ASN G 334
THR G 413
NAG  G 511 (-1.9A)
None
NAG  G 508 (-1.8A)
None
1.25A 4d1yA-5f9oG:
undetectable
4d1yB-5f9oG:
undetectable
4d1yA-5f9oG:
19.43
4d1yB-5f9oG:
19.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FU9_A_ACTA312_0
(UROKINASE-TYPE
PLASMINOGEN
ACTIVATOR)
5f9o CH235.9 HEAVY CHAIN
(Homo
sapiens)
3 / 3 ARG H  98
HIS H 111
TYR H  32
None
1.24A 4fu9A-5f9oH:
undetectable
4fu9A-5f9oH:
22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K50_A_ACTA502_0
(RNA POLYMERASE
3D-POL)
5f9o CLADE A/E 93TH057
HIV-1 GP120 CORE

(Human
immunodeficiency
virus
1)
3 / 3 ARG G 327
LYS G 328
LYS G 325
EPE  G 514 ( 4.0A)
None
None
1.30A 4k50A-5f9oG:
undetectable
4k50A-5f9oG:
20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K50_E_ACTE502_0
(RNA POLYMERASE
3D-POL)
5f9o CLADE A/E 93TH057
HIV-1 GP120 CORE

(Human
immunodeficiency
virus
1)
3 / 3 ARG G 327
LYS G 328
LYS G 325
EPE  G 514 ( 4.0A)
None
None
1.36A 4k50E-5f9oG:
undetectable
4k50E-5f9oG:
20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K50_I_ACTI506_0
(RNA POLYMERASE
3D-POL)
5f9o CLADE A/E 93TH057
HIV-1 GP120 CORE

(Human
immunodeficiency
virus
1)
3 / 3 ARG G 327
LYS G 328
LYS G 325
EPE  G 514 ( 4.0A)
None
None
1.36A 4k50I-5f9oG:
undetectable
4k50I-5f9oG:
20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVW_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)
5f9o CH235.9 HEAVY CHAIN
(Homo
sapiens)
5 / 11 ALA H 146
THR H 192
GLY H 143
GLY H 142
SER H 141
None
1.06A 4qvwK-5f9oH:
undetectable
4qvwL-5f9oH:
undetectable
4qvwK-5f9oH:
23.39
4qvwL-5f9oH:
22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVW_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)
5f9o CH235.9 HEAVY CHAIN
(Homo
sapiens)
5 / 11 ALA H 146
THR H 192
GLY H 143
GLY H 142
SER H 141
None
1.06A 4qvwY-5f9oH:
undetectable
4qvwZ-5f9oH:
undetectable
4qvwY-5f9oH:
23.39
4qvwZ-5f9oH:
22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NWU_A_ACAA18_2
(WTFP-TAG,GP41)
5f9o CH235.9 HEAVY CHAIN
(Homo
sapiens)
3 / 3 LEU H 107
LEU H 106
TRP H  50
None
0.89A 5nwuA-5f9oH:
undetectable
5nwuA-5f9oH:
12.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XDH_C_DAHC60_1
(PUTATIVE CYTOCHROME
C)
5f9o CLADE A/E 93TH057
HIV-1 GP120 CORE

(Human
immunodeficiency
virus
1)
4 / 6 HIS G 374
ASN G 377
VAL G 255
LEU G 260
None
1.28A 5xdhA-5f9oG:
undetectable
5xdhC-5f9oG:
undetectable
5xdhA-5f9oG:
10.34
5xdhC-5f9oG:
10.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZNI_A_YMZA302_0
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
5f9o CH235.9 HEAVY CHAIN
(Homo
sapiens)
5 / 9 VAL H  68
GLY H   8
TYR H  94
MET H  81
GLY H  10
None
1.20A 5zniA-5f9oH:
undetectable
5zniA-5f9oH:
17.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BPY_A_ACTA408_0
(THIOREDOXIN
REDUCTASE)
5f9o CH235.9 HEAVY CHAIN
(Homo
sapiens)
3 / 3 PRO H 194
SER H 196
SER H 197
None
0.66A 6bpyA-5f9oH:
undetectable
6bpyA-5f9oH:
19.69